Clinical trial
Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy
NCT05233540 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy
- Lead sponsor
- Aarhus University Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2022
- Completion date
- December 31, 2025
- Enrollment
- 60 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
anal cancer, circulating tumor cell, human papilloma virus, locally advanced squamous cell carcinoma, oligometastatic disease